Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Camm

Showing results (41-50 of 662) with videos related to

Pageof 67
Sort By:
Current Cardiology Reviews|May 14, 2014
The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 4, 2023
Leap or lag: left atrial appendage closure and guidelinesA John Camm
Arrhythmia & Electrophysiology Review|February 3, 2016
The Role of Continuous Monitoring in Atrial Fibrillation ManagementA John Camm
European Heart Journal|November 11, 2020
Does ablation of atrial fibrillation reduce the likelihood of dementia? A step closer but not yet thereA John Camm
International Journal of Cardiology|January 15, 2008
Safety considerations in the pharmacological management of atrial fibrillationA John Camm
European Heart Journal|September 23, 2009
The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarinA John Camm
Clinical Therapeutics|April 20, 2010
Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosisA John Camm
European Heart Journal|March 16, 2019
Left atrial ablation for management of atrial fibrillation: CABANA vs. real-world data. Apples and oranges?A John Camm
Journal of Internal Medicine|November 6, 2012
Managing anticoagulation for atrial fibrillation: current issues and future strategiesA John Camm
Thrombosis and Haemostasis|March 23, 2018
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic DiseaseA John Camm
Pageof 67

Showing results (41-50 of 662) with videos related to

Sort By:
Pageof 67
Current Cardiology Reviews|May 14, 2014
The vernakalant story: how did it come to approval in Europe and what is the delay in the U.S.A?A John Camm
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 4, 2023
Leap or lag: left atrial appendage closure and guidelinesA John Camm
Arrhythmia & Electrophysiology Review|February 3, 2016
The Role of Continuous Monitoring in Atrial Fibrillation ManagementA John Camm
European Heart Journal|November 11, 2020
Does ablation of atrial fibrillation reduce the likelihood of dementia? A step closer but not yet thereA John Camm
International Journal of Cardiology|January 15, 2008
Safety considerations in the pharmacological management of atrial fibrillationA John Camm
European Heart Journal|September 23, 2009
The RE-LY study: Randomized Evaluation of Long-term anticoagulant therapY: dabigatran vs. warfarinA John Camm
Clinical Therapeutics|April 20, 2010
Review of the cardiovascular safety of zoledronic acid and other bisphosphonates for the treatment of osteoporosisA John Camm
European Heart Journal|March 16, 2019
Left atrial ablation for management of atrial fibrillation: CABANA vs. real-world data. Apples and oranges?A John Camm
Journal of Internal Medicine|November 6, 2012
Managing anticoagulation for atrial fibrillation: current issues and future strategiesA John Camm
Thrombosis and Haemostasis|March 23, 2018
The Rivaroxaban Program and the Management of Unmet Needs in Thromboembolic DiseaseA John Camm
Pageof 67